AI toxicity & ADMET predictionconfirmed

Inductive Bio

ADMET prediction software (Compass) trained on a precompetitive data consortium; plans an AI-native CRO layer.

Notable

Placed first in the Polaris ADMET competition (2025) and the OpenADMET-ExpansionRx blind challenge (Feb 2026, 370+ submissions).

Dec 4, 2025
Government funding, ARPA-H CATALYST
DATAMAP project to build AI liver and heart toxicity models trained on organoid, ex vivo tissue and MPS data, with FDA input on regulatory fit.
up to $21M
pharmaceutical-technology.com(opens in new tab)
May 7, 2025
Venture financing, Series A
Series A to expand its ADMET data consortium and Compass prediction software.
$25M
biopharmatrend.com(opens in new tab)
Dec 13, 2023
Venture financing, Seed
Seed round for machine learning models of small-molecule ADMET.
$4.3M
alleywatch.com(opens in new tab)

Feb 3, 2026
Inductive Bio tops the OpenADMET-ExpansionRx blind challenge
biopharmatrend.com(opens in new tab)